Reference

• Anti-androgenic activities of Ganoderma lucidum; Rumi Fujita, Jie Liu, Kuniyoshi Shimizu, Fumiko Konishi, Kiyoshi Noda, Shoichiro Kumamoto, Chie Ueda, Hisatoshi Tajiri, Shuhei Kaneko, Yoshitaro Suimi and Ryuichiro Kondo; Department of Forest and Forest Products Science, Faculty of Agriculture, Kyushu University, Fukuoka 812-8581, Japan
• The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum; Jie Liu, Kuniyoshi Shimizu, Fumiko Konishi, Shoichiro Kumamoto and Ryuichiro Kondo; Department of Forest and Forest Products Science, Faculty of Agriculture, Kyushu University, Fukuoka 812-8581, Japan
• Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells; Ben-Zion Zaidman, Solomon P. Wasser, Eviatar Nevo and Jamal Mahajna; Institute of Evolution, University of Haifa, Mount Carmel, Haifa, 31905, Israel
• Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3; Jiang J, Slivova V, Valachovicova T, Harvey K, Sliva D; Cancer Research Laboratory, Methodist Research Institute, E504, Indianapolis, IN 46202, USA
• Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-β1 from prostate cancer cells; Gwenaelle Stanley, Kevin Harvey, Veronika Slivova, Jiahua Jiang and Daniel Sliva; Cancer Research Laboratory, Methodist Research Institute, 1800 N Capitol Ave, E504, Indianapolis, IN 46202, USA
• Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells; Daniel Sliva, Carlos Labarrere, Veronika Slivova, Miroslav Sedlak, Frank P. Lloyd, Jr. and Nancy W. Y. Ho; Cancer Research Laboratory, Methodist Research Institute, 1800 N Capitol Ave, E504, Indianapolis, IN 46202, USA